MétaCan
Menu
Back to cohort
Record W2904059000 · doi:10.1093/eurheartj/ehy653

Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies

2018· review· en· W2904059000 on OpenAlexaff
Lisa Pennells, Stephen Kaptoge, Angela Wood, Xiaohui Zhao, Ian R. White, Stephen Burgess, Peter Willeit, Thomas Bolton, Karel G.M. Moons, Yvonne T. van der Schouw, Randi Selmer, Vilmundur Guðnason, Gerd Assmann, Philippe Amouyel, Veikko Salomaa, Mika Kivimäki, Børge G. Nordestgaard, Michael J. Blaha, Lewis H. Kuller, Hermann Brenner, Richard F Gillum, Christa Meisinger, Ian Ford, Matthew Knuiman, Annika Rosengren, Debbie A. Lawlor, Henry Völzke, Cyrus Cooper, Alejandro Marín Ibañez, Edoardo Casiglia, Jussi Kauhanen, Jackie A. Cooper, Beatriz L. Rodríguez, Johan Sundström, Elizabeth Barrett‐Connor, Rachel Dankner, Paul J. Nietert, Karina W. Davidson, Robert B. Wallace, Dan G. Blazer, Cecilia Björkelund, Chiara Donfrancesco, Harlan M. Krumholz, Aulikki Nissinen, Barry R. Davis, Sean Coady, Peter H. Whincup, Torben Jørgensen, Maurizio Trevisan, Gunnar Engström, Carlos J. Crespo, Tom Meade, Marjolein Visser, Daan Kromhout, Stefan Kiechl, Makoto Daimon, Jackie F. Price, Agustı́n Gómez de la Cámara, J. Wouter Jukema, Benoı̂t Lamarche, Altan Onat, Leon A. Simons, Maryam Kavousi, Yoav Ben‐Shlomo, Joost Dekker, Hisatomi Arima, Nawar Shara, Robert Tipping, Ronan Roussel, Masaru Sakurai, Jelena Pavlović, Ron T. Gansevoort, Dorothea Nagel, Uri Goldbourt, Elizabeth Barr, Luigi Palmieri, Inger Njølstad, Shin-ichi Sato, W. M. Monique Verschuren, Cherian Varghese, Ian Graham, Oyere Onuma, Philip Greenland, Mark Woodward, Majid Ezzati, Bruce M. Psaty, Rod Jackson, Paul M. Ridker, Nancy R. Cook, Ralph B. D’Agostino, Simon G. Thompson, John Danesh, Emanuele Di Angelantonio, Lara M. Simpson, Sara Pressel, David Couper, Vijay Nambi, Kunihiro Matsushita, Aaron R. Folsom, Jonathan E Shaw, Dianna J. Magliano, Paul Zimmet, S. Goya Wannamethee, Johann Willeit, Peter Santer, Georg Egger, Juan P. Casas, Antointtte Amuzu, John Gallacher, Valérie Tikhonoff, Susan E. Sutherland, Mary Cushman, Anne Johanne Søgaard, Lise Lund Håheim, Inger Ariansen, Anne Tybjærg‐Hansen, Gorm Boje Jensen, Peter Schnohr, Simona Giampaoli, Diego Vanuzzo, Salvatore Panico, Beverley Balkau, Fabrice Bonnet, Michel Marre, Miguel A. Rubio, Yechiel Friedlander, John McCallum, Stela McLachlan, Jack M. Guralnik, Caroline L. Phillips, Ben Schöttker, Kai‐Uwe Saum, Bernd Holleczek, Hanna Tolonen, Erkki Vartiainen, Kennet Harald, Joseph M. Massaro, Michael Pencina, Ramachandran S. Vasan, Takamasa Kayama, Takeo Kato, Toshihide Oizumi, Jørgen Jespersen, Lars Møller, Else‐Marie Bladbjerg, Angela Chetrit, Lars Wilhelmsen, Lauren Lissner, Elaine Dennison, Yutaka Kiyohara, Toshiharu Ninomiya, Yasufumi Doi, Giel Nijpels, Coen D.A. Stehouwer, Yamagishi Kazumasa, Sudhir Kurl, Tomi-Pekka Tuomainen, Jukka T. Salonen, D.J.H. Deeg, Peter M. Nilsson, Bo Hedblad, Olle Melander, Ian H. de Boer, Andrew P. DeFilippis, Graham Watt, Wolfgang Köenig, Aage Tverdal, Susan Kirkland, Daichi Shimbo, Jonathan A. Shaffer, Stephan J. L. Bakker, Pim van der Harst, Hans L. Hillege, Jean Dallongeville, H. Schulte, Stella Trompet, Roelof A. J. Smit, David J. Stott, Jean‐Pierre Després, Bernard Cantin, Gilles R. Dagenais, Gail A. Laughlin, Deborah L. Wingard, Kay-Tee Khaw, Thor Aspelund, Guðný Eiríksdóttir, Elías F. Guðmundsson, M. Arfan Ikram, Frank J.A. van Rooij, Oscar H. Franco, Oscar L. Rueda‐Ochoa, Taulant Muka, Marija Glišić, Hugh Tunstall‐Pedoe, Barbara V. Howard, Ying Zhang, Stacey E. Jolly, Günay Can, Hüsniye Yüksel, Hideaki Nakagawa, Yuko Morikawa, Katsuyuki Miura, Martin Ingelsson, Vilmantas Giedraitis, J. Michael Gaziano, Arndt Volker, Naveed Sattar, Johanna M. Geleijnse

Bibliographic record

VenueEuropean Heart Journal · 2018
Typereview
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsUniversité Laval
FundersNational Heart, Lung, and Blood InstituteNIHR Cambridge Biomedical Research CentreMedical Research CouncilMerck Sharp and DohmeVersus ArthritisServierFONDATION ALZHEIMERSyddansk UniversitetNovo NordiskNederlandse Organisatie voor Wetenschappelijk OnderzoekRijksuniversiteit GroningenWorld Health OrganizationWellcome TrustCancer Research UKNational Institute of Environmental Health SciencesDaiichi-SankyoNHS Blood and TransplantNational Institute for Health and Care ResearchMedicines CompanyNational Institutes of HealthÖsterreichische ForschungsförderungsgesellschaftRegeneron PharmaceuticalsYale UniversityBritish Heart FoundationBrigham and Women's HospitalEuropean CommissionH2020 European Research CouncilKowa CompanySanofiSingulexAmgenPfizerErasmus Universiteit RotterdamAstraZenecaEli Lilly and CompanyAmerican Heart AssociationAetna Foundation
KeywordsMedicineMeta-analysisEqualization (audio)AlgorithmProspective cohort studyInternal medicine

Abstract

fetched live from OpenAlex

AIMS: There is debate about the optimum algorithm for cardiovascular disease (CVD) risk estimation. We conducted head-to-head comparisons of four algorithms recommended by primary prevention guidelines, before and after 'recalibration', a method that adapts risk algorithms to take account of differences in the risk characteristics of the populations being studied. METHODS AND RESULTS: Using individual-participant data on 360 737 participants without CVD at baseline in 86 prospective studies from 22 countries, we compared the Framingham risk score (FRS), Systematic COronary Risk Evaluation (SCORE), pooled cohort equations (PCE), and Reynolds risk score (RRS). We calculated measures of risk discrimination and calibration, and modelled clinical implications of initiating statin therapy in people judged to be at 'high' 10 year CVD risk. Original risk algorithms were recalibrated using the risk factor profile and CVD incidence of target populations. The four algorithms had similar risk discrimination. Before recalibration, FRS, SCORE, and PCE over-predicted CVD risk on average by 10%, 52%, and 41%, respectively, whereas RRS under-predicted by 10%. Original versions of algorithms classified 29-39% of individuals aged ≥40 years as high risk. By contrast, recalibration reduced this proportion to 22-24% for every algorithm. We estimated that to prevent one CVD event, it would be necessary to initiate statin therapy in 44-51 such individuals using original algorithms, in contrast to 37-39 individuals with recalibrated algorithms. CONCLUSION: Before recalibration, the clinical performance of four widely used CVD risk algorithms varied substantially. By contrast, simple recalibration nearly equalized their performance and improved modelled targeting of preventive action to clinical need.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.017
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Meta-epidemiology (broad)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.092
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0170.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0120.016
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.405
GPT teacher head0.417
Teacher spread0.011 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations165
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Heart JournalSame topicLipoproteins and Cardiovascular HealthFrench-language works237,207